ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Puts Clinical Hold On Gene Therapy Trials

January 24, 2003

The Pink Machine Sputters, Goes in Reverse: Komen Funding Decision Sparks Outrage

February 3, 2012

In Brief: Longmire Reappointed to Panel; New Organ System Group For Brain-CNS Tumors Asked

April 26, 1985

Clinical Study Group Proposed To Examine Peer Review System

October 15, 1993

Overdiagnosis Can Result In Harm To Patients, Experts Say.

November 3, 2006

Taxol Released On Compassionate Use Basis To Centers; Ohio, Columbia Begin Treatments

October 18, 1991